Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARA CVE:DBG CVE:GMA NASDAQ:OM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsDBGDoubleview GoldC$0.61C$0.65C$0.29▼C$0.89C$131.24M1.27244,066 shs69,558 shsGMAGeomega ResourcesC$0.23-2.1%C$0.17C$0.07▼C$0.28C$32.98M1.8898,642 shs53,307 shsOMOutset Medical$17.42-1.0%$19.29$5.85▼$62.10$311.91M2.15156,165 shs319,110 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%DBGDoubleview Gold-3.17%-10.29%-7.58%-15.28%+90.63%GMAGeomega Resources-4.08%+9.30%+30.56%+56.67%+123.81%OMOutset Medical-2.76%-14.60%-7.07%+59.85%-73.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARAAmerican Renal AssociatesN/AN/AN/AN/AN/AN/AN/AN/ADBGDoubleview Gold1.7864 of 5 stars3.50.00.00.02.01.70.0GMAGeomega ResourcesN/AN/AN/AN/AN/AN/AN/AN/AOMOutset Medical1.463 of 5 stars3.51.00.00.02.20.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARAAmerican Renal Associates 0.00N/AN/AN/ADBGDoubleview Gold 3.00BuyC$1.39127.87% UpsideGMAGeomega Resources 0.00N/AN/AN/AOMOutset Medical 3.00Buy$29.5069.35% UpsideCurrent Analyst Ratings BreakdownLatest GMA, DBG, OM, and ARA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/14/2025OMOutset MedicalBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$37.005/21/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.005/15/2025OMOutset MedicalScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/8/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45DBGDoubleview GoldN/AN/AC$0.03 per share19.09C$0.13 per shareN/AGMAGeomega ResourcesC$154.21K213.87C$0.06 per share4.12C$0.03 per share7.67OMOutset Medical$113.69M2.72N/AN/A$7.49 per share2.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/ADBGDoubleview Gold-C$1.54M-C$0.01N/A∞N/AN/A-6.64%-7.42%N/AGMAGeomega Resources-C$2.02M-C$0.01N/A∞N/AN/A-45.52%-26.01%N/AOMOutset Medical-$127.98M-$29.15N/A∞N/A-98.74%-143.62%-37.50%8/6/2025 (Estimated)Latest GMA, DBG, OM, and ARA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025OMOutset Medical-$1.76N/AN/AN/A$29.40 millionN/A5/7/2025Q1 2025OMOutset Medical-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARAAmerican Renal AssociatesN/AN/AN/AN/AN/ADBGDoubleview GoldN/AN/AN/AN/AN/AGMAGeomega ResourcesN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARAAmerican Renal Associates7.541.051.02DBGDoubleview GoldN/A2.375.69GMAGeomega Resources62.122.176.08OMOutset Medical0.578.376.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARAAmerican Renal Associates78.42%DBGDoubleview Gold0.10%GMAGeomega ResourcesN/AOMOutset MedicalN/AInsider OwnershipCompanyInsider OwnershipARAAmerican Renal Associates9.50%DBGDoubleview Gold18.15%GMAGeomega Resources4.15%OMOutset Medical2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableDBGDoubleview GoldN/A215.15 millionN/ANot OptionableGMAGeomega ResourcesN/A143.40 millionN/ANot OptionableOMOutset Medical52017.72 million17.30 millionNot OptionableGMA, DBG, OM, and ARA HeadlinesRecent News About These CompaniesC WorldWide Group Holding A S Sells 933,334 Shares of Outset Medical, Inc. (NASDAQ:OM)July 18 at 10:27 AM | marketbeat.comOutset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025July 16 at 4:03 PM | globenewswire.comWhy Outset Medical's Rock-Bottom Valuation Masks Explosive GrowthJuly 7, 2025 | seekingalpha.comOutset Medical (NASDAQ:OM) Shares Up 0.7% - Time to Buy?July 1, 2025 | marketbeat.comStrength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?June 25, 2025 | zacks.comOutset Medical, Inc. (OM) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comOutset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceJune 5, 2025 | globenewswire.comFormer Shockwave CFO joins Outset Medical in the same roleJune 4, 2025 | massdevice.comOutset Medical Appoints Renee Gaeta as Chief Financial OfficerJune 3, 2025 | globenewswire.comOutset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed Sells 584 SharesMay 17, 2025 | insidertrades.comOutset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of DirectorsMay 15, 2025 | uk.finance.yahoo.comOutset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of DirectorsMay 14, 2025 | globenewswire.comOutset Medical to Present at RBC Global Healthcare ConferenceMay 9, 2025 | globenewswire.comOutset Medical, Inc. (OM) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comOutset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue EstimatesMay 7, 2025 | zacks.comOutset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use DeclinedMay 7, 2025 | globenewswire.comOUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmApril 29, 2025 | globenewswire.comDoes Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect?April 21, 2025 | zacks.comOutset Medical, Inc. Announces Q1 2025 Financial Results Release and Conference Call DetailsApril 16, 2025 | quiverquant.comQOutset Medical: The Worst Is Over, But Execution Risk Remains HighApril 16, 2025 | seekingalpha.comAnalysts Conflicted on These Healthcare Names: Outset Medical (OM) and AptarGroup (ATR)April 16, 2025 | markets.businessinsider.comMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack Mode3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI SpendingGMA, DBG, OM, and ARA Company DescriptionsAmerican Renal Associates NYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.Doubleview Gold CVE:DBGC$0.61 0.00 (0.00%) As of 02:48 PM EasternDoubleview Gold Corp. engages in the acquisition, exploration, and development of mineral resource properties in British Columbia. The company explores for copper, gold, silver, and zinc deposits. It holds a 100% interest in the Hat property with nine mineral claims covering an area of approximately 3,561.43 hectares located in northwestern British Columbia; and 90% interests in the Red Spring property that comprise 6 mineral claims, which covers an area of approximately 4,224.34 hectares situated in Omineca district, British Columbia. The company was formerly known as Doubleview Capital Corp. and changed its name to Doubleview Gold Corp. in May 2020. Doubleview Gold Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.Geomega Resources CVE:GMAC$0.23 -0.01 (-2.13%) As of 03:59 PM EasternGeomega Resources Inc. engages in the acquisition, evaluation, and exploration of mining properties in Canada. The company primarily explores for rare earth elements and niobium deposits. It owns a 100% interest in the Montviel property comprising 106 mining claims covering an area of approximately 5,889 hectares located 100 km north of Lebel-surQuévillon and 45 km west of the Cree First Nation of Waswanipi. The company was incorporated in 2008 and is headquartered in Boucherville, Canada.Outset Medical NASDAQ:OM$17.42 -0.18 (-1.02%) Closing price 04:00 PM EasternExtended Trading$17.74 +0.31 (+1.81%) As of 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
